BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24297539)

  • 1. Challenges in secondary analysis of high throughput screening data.
    Blucher AS; McWeeney SK
    Pac Symp Biocomput; 2014; ():114-24. PubMed ID: 24297539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Web-based drug repurposing tools: a survey.
    Sam E; Athri P
    Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of off-target drug effects through data fusion.
    Yera ER; Cleves AE; Jain AN
    Pac Symp Biocomput; 2014; 19():160-71. PubMed ID: 24297543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of network-based approaches to drug repositioning.
    Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
    Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale integration of heterogeneous pharmacogenomic data for identifying drug mechanism of action.
    Luo Y; Wang S; Xiao J; Peng J
    Pac Symp Biocomput; 2018; 23():44-55. PubMed ID: 29218868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO).
    Vempati UD; Przydzial MJ; Chung C; Abeyruwan S; Mir A; Sakurai K; Visser U; Lemmon VP; Schürer SC
    PLoS One; 2012; 7(11):e49198. PubMed ID: 23155465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
    Shameer K; Readhead B; Dudley JT
    Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current progress in high-throughput screening for drug repurposing.
    Khambhati K; Siruka D; Ramakrishna S; Singh V
    Prog Mol Biol Transl Sci; 2024; 205():247-257. PubMed ID: 38789182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
    Yang CC; Zhao M
    Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension.
    Wu P; Feng Q; Kerchberger VE; Nelson SD; Chen Q; Li B; Edwards TL; Cox NJ; Phillips EJ; Stein CM; Roden DM; Denny JC; Wei WQ
    Nat Commun; 2022 Jan; 13(1):46. PubMed ID: 35013250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
    Guney E
    Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Getting the most out of PubChem for virtual screening.
    Kim S
    Expert Opin Drug Discov; 2016 Sep; 11(9):843-55. PubMed ID: 27454129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug databases and their contributions to drug repurposing.
    Masoudi-Sobhanzadeh Y; Omidi Y; Amanlou M; Masoudi-Nejad A
    Genomics; 2020 Mar; 112(2):1087-1095. PubMed ID: 31226485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing from the perspective of pharmaceutical companies.
    Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
    Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PubChem BioAssay: A Decade's Development toward Open High-Throughput Screening Data Sharing.
    Wang Y; Cheng T; Bryant SH
    SLAS Discov; 2017 Jul; 22(6):655-666. PubMed ID: 28346087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug ReposER: a web server for predicting similar amino acid arrangements to known drug binding interfaces for potential drug repositioning.
    Ab Ghani NS; Ramlan EI; Firdaus-Raih M
    Nucleic Acids Res; 2019 Jul; 47(W1):W350-W356. PubMed ID: 31106379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.
    Lee H; Kang S; Kim W
    PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.